Ładuje się......
Competitive SPR using an intracellular anti-LMO2 antibody identifies novel LMO2-interacting compounds
The use of intracellular antibodies as templates to derive surrogate compounds is an important objective because intracellular antibodies can be employed initially for target validation in pre-clinical assays and subsequently employed in compound library screens. LMO2 is a T cell oncogenic protein a...
Zapisane w:
| Wydane w: | J Immunol Methods |
|---|---|
| Główni autorzy: | , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Elsevier
2021
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8208243/ https://ncbi.nlm.nih.gov/pubmed/33794223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jim.2021.113051 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|